Viewing nowCombinationTwinex Tablets 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceuticals Co., Ltd.

MFDS item code 201706787 · Approved 2017.08.23 · Insurance code 661904830
Treatment of essential hypertension not controlled by monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with telmisartan or amlodipine monotherapy. It helps to effectively lower blood pressure and reduce the risk of cardiovascular complications.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg and 80/10 mg). ◦ Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution in Administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
◦ Children: Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus or newborn, especially during the second and third trimesters of pregnancy, and should be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients who are allergic to the active ingredients or similar components, pregnant or potentially pregnant women, breastfeeding women, or patients with severe liver or heart problems. Patients with liver or heart disease, impaired kidney function, certain heart valve diseases, and the elderly should exercise special caution when taking this medication. Common side effects may include dizziness, swelling, headache, and indigestion, and serious side effects may occur rarely, so if any unusual symptoms appear, you should consult a doctor immediately. Due to the risks of hypotension, hyperkalemia, and abnormal kidney function, it is important to regularly check blood pressure and conduct blood tests to monitor your condition. When taking this medication in conjunction with other drugs, there may be interactions, so you must inform your healthcare provider about any medications you are currently taking. It is advisable to avoid this medication during pregnancy or breastfeeding and consult for other safe alternative treatments if necessary. Safety and efficacy have not been sufficiently established for children, so its use is not recommended. In cases of overdose, severe hypotension or heart problems may occur, so it is crucial to adhere to the prescribed dosage and visit a medical facility immediately if side effects arise. This medication should be kept out of reach of children and should not be transferred to another container; it is best to open the packaging just before use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an opaque container. Additionally, it is important to maintain a temperature between 1 degree and 30 degrees Celsius when storing the medication to preserve its effectiveness and safety.
White or off-white rectangular tablet
30 tablets (10 tablets/Alu-Alu × 3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceuticals Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.